Your session is about to expire
← Back to Search
Caretaker Device for Complications
N/A
Waitlist Available
Led By Timothy Harwood, MD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-op hour 24, post-op hour 24
Awards & highlights
Study Summary
This trial will help to determine if the Caretaker device is an accurate way to measure vital signs.
Eligible Conditions
- Perioperative/Postoperative Complications
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ pre-op hour 24, post-op hour 24
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre-op hour 24, post-op hour 24
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Caretaker Data Capture Rate
Ease of Use Determined by Number of Participants With Sleep or Activities of Daily Living (ADLs) Interference
Monitor Return Rate
+2 moreSecondary outcome measures
Arterial Oxygen Saturation (SaO2)
Average Length of Hospital Stay
Heart rate
+11 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Caretaker DeviceExperimental Treatment1 Intervention
participants will undergo active CareTaker monitoring for 24-48 hours
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Caretaker Device placement
2021
N/A
~50
Find a Location
Who is running the clinical trial?
Wake Forest University Health SciencesLead Sponsor
1,240 Previous Clinical Trials
1,004,146 Total Patients Enrolled
Timothy Harwood, MDPrincipal InvestigatorWake Forest University Health Sciences
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have had surgery on your arms or hands.
Research Study Groups:
This trial has the following groups:- Group 1: Caretaker Device
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are any openings currently available for enrolment in this trial?
"Affirmative. Clinicaltrials.gov has the most up-to-date information, and it reveals that this clinical research is still seeking enrolment. It was initially posted on August 18th 2021, with its last modification taking place on September 27th 2022; a total of 150 subjects are needed from one trial location."
Answered by AI
What is the highest number of volunteers enrolled in this trial?
"Affirmative. According to the information on clinicaltrials.gov, this medical experiment is actively seeking participants after first being posted on August 18th 2021 and last updated on September 27th 2022. There are 150 openings at a single trial site."
Answered by AI
Share this study with friends
Copy Link
Messenger